The Future of Public Health: Preventing ill-health and promoting healthy behaviours

By Karen Taylor and Samrina Bhatti, Deloitte Centre for Health Solutions

LSHC blog banner image 28 Jan 2022

This week, we launched the fourth report in our future of public health series, Negating the gap:  Preventing ill health and promoting healthy behaviours, highlighting the unequal impact of the COVID-19 pandemic and how failing to focus more on preventative services has disproportionately affected people living in more economically disadvantaged areas. It considers how recent policy changes, such as the introduction of Integrated Care Systems (ICSs) and the establishment of the Office of Health Improvement and Disparities (OHID), provides an opportunity to increase the priority given to prevention; and identifies that increasing healthy life years and reducing inequalities requires a population health management (PHM) approach and more effective and targeted funding for prevention. This week’s blog provides an overview of our main findings and why a more concerted effort on ill-health prevention and health promotion is needed.

Continue reading

Posted on 28/01/2022 | 0 Comments

The State of the State 2021-22: a new normal for health and care?

By Aiden Hannah, Research Analyst, and Karen Taylor, Director, Deloitte Centre for Health Solutions

LSHC blog banner image 21 Jan 2022

In November 2021, Deloitte’s public sector team together with the think tank Reform published their tenth annual report ‘The State of the State 2021-22: Towards a new public sector normal’. The report recognises that, since March 2020, the UK governments and public services have led radical, exhaustive, and dynamic responses to the COVID-19 pandemic. During this past year, they have had to deal with both the pandemic and its wider repercussions in seeking to establish a ‘new normal’. Unsurprisingly, health and social care feature throughout the commentary. Our blog this week provides our take on the report’s key findings on the NHS and social care, supplemented where relevant with observations from our own research.

Continue reading

Posted on 21/01/2022 | 0 Comments

Measuring the return from pharmaceutical innovation – nurturing growth

By Emily May, Assistant Manager, UK Centre for Health Solutions

LSHC blog banner image 13 Jan 2022

Since 2010, we have examined biopharmaceutical (biopharma) R&D by tracking the returns that leading global biopharma companies might expect to achieve from their late-stage pipelines. Yesterday we launched Nurturing growth: Measuring the return from pharmaceutical innovation 2021, the 12th report in our series which shows that in 2021 our cohort of 15 high spending R&D companies have seen a large uptick in the average internal rate of return (IRR). This is driven largely by reduced average costs to develop an asset, reduced cycle times and increased average sales forecasts. This week’s blog explores these 2021 report findings and discusses how companies can learn the lessons from the past 12 months to realise a productive future for drug development.

Continue reading

Posted on 13/01/2022 | 0 Comments

How digital technology is changing healthcare: A physiotherapists perspective

By Dylan Powell, Research Analyst, Deloitte

LSHC blog banner image 7 Jan 2022

Since its inception in 1948, the National Health Service (NHS) has transformed and evolved to be one of the biggest employers globally (1.5 million employees).1 However, despite this, over the past 22 months of the pandemic has had a significant impact on many aspects of healthcare delivery and exposed the limitations and fragility of the current volume-based healthcare system. It is a system that is struggling to meet the increasing demand and expectations of society, government, staff and most importantly patients. One of the most visible outcomes of this struggle is the increase in waiting times for both emergency treatment and elective surgery. Today, an estimated 5.6 million people are waiting for routine elective procedures, a number that is expected to grow to some 13 million people in a few years unless new ways of working are adopted.2 This week’s blog, by our new analyst Dylan Powell, considers how the use of digital technology and a more preventative self-management model is changing physiotherapy and could help to manage healthcare pressures effectively.

Continue reading

Posted on 07/01/2022 | 0 Comments

The Future of Public Health: Bridging the gap

By Karen Taylor and Samrina Bhatti, Deloitte Centre for Health Solutions

LSHC blog banner image 17 Dec

This week, we launched the third report in our future of public health series, Bridging the gap: Protecting the nation from public health threats. Health protection requires targeted and cross‑functional approaches to tackle multiple, diverse and challenging public health threats. These threats need to be managed in an optimal way to reduce health inequalities, avoidable disability and premature death. Our ‘Bridging the gap’ report examines the UK’s policies and approaches to health protection. The pandemic has, however, exposed critical gaps in the health protection system, including workforce and funding shortages, a lack of surveillance capacity, and fragmented and unclear accountabilities. This week’s blog discusses the challenges pre-COVID-19, the impact of the pandemic and what the future might hold, based on key findings in our third public health report.

Continue reading

Posted on 17/12/2021 | 0 Comments

Reducing health inequalities and improving access to medicine through access and affordability programmes

By Elizabeth Hampson, Director Monitor Deloitte

LSHC blog banner image 5 Dec

Today, over a quarter of the world’s population has no access to essential medicines and, for more than two billion people worldwide, medicines may be unaffordable, unavailable, inaccessible or non-quality assured.1 2 With statistics this stark, and the increased awareness (due to the COVID-19 pandemic) of the impact of both global and national health inequalities on health outcomes, there is a need for much better awareness and more targeted action to improve access to medicine for all.

Continue reading

Posted on 10/12/2021 | 0 Comments

Exploring the future of diagnostics in the UK

By Aiden Hannah, Research Analyst, Deloitte

LSHC blog banner image 3 Dec

In November 2020 our report, ‘The future unmasked: Predicting the future of healthcare and life sciences in 2025’ included a prediction that technological breakthroughs would create new diagnostic pathways, enabling clinicians to deliver hyper-personalised evidence-based prevention and treatment interventions.1 Over the past year the pandemic has continued to have a significant impact upon the healthcare industry, in particular the diagnostics industry. This week’s blog, by our new analyst Aiden Hannah, considers the lasting impact of some of these changes and what the diagnostics landscape may look like in the future.

Continue reading

Posted on 03/12/2021 | 0 Comments

Healthcare regulation in England is changing: how should ICSs and ICBs respond?

By Matt Quinn, Manager and Dan Donaghy, Director, UK Public Sector Enterprise Operations team

LSHC blog banner image 25 Nov

The impending establishment of Integrated Care Boards (ICBs) as statutory entities from April 2022 means that regulators are adapting their regulatory models. This is to ensure a proportionate response for a ‘Systems’ based world. This also heralds a period of flux for health and social care regulation in England at a time of unprecedented demand and operational pressure precipitated by the pandemic. Health and social care organisations will need to respond to this new regulatory regime and change their operating models to ensure their leadership, financial, safety and quality performance meet regulatory expectations. In this blog, we discuss some suggested areas of change informed by our recent work in the area.

Continue reading

Posted on 25/11/2021 | 0 Comments

The Future of Public Health: Identifying the gap

By Karen Taylor and Samrina Bhatti, Deloitte Centre for Health Solutions

LSHC blog banner image 19 Nov

On 9 November, we launched the second in our future of public health report series, Identifying the gap; Understanding the drivers of inequality in public health. This report examines the who what and why of public health and the political social and economic drivers affecting public health. It also explains why learning the lessons from the past, including the lessons learned in responding to the COVID-19 pandemic, is crucial if the UK is to avoid repeating past mistakes and their reforms of the public health system are to be effective. This week’s blog explores  the historical and current challenges and approaches being taken to tackle the ‘wicked problems’ affecting public health.

Continue reading

Posted on 19/11/2021 | 0 Comments

Movember 2021: Grow a 'mo’ to save a ‘bro’ - raising awareness for men’s health

By Andy Haywood, Campaign Account Manager, Deloitte

LSHC blog banner image 12 Nov

Movember is upon us, marked by the emergence of upper-lip fuzz on men across the world. Since 2003, the Movember Foundation’s unrelenting goal has been to raise awareness of men’s health issues, with a particular focus on prostate cancer, testicular cancer and mental health and suicide prevention. Movember also seeks to challenge the status quo, shake up men’s health research and transform the way health services reach and support men. During the month formerly known as November, Mo Bros and Mo Sisters around the world rally in support of the cause to get people talking about these vital health issues. This week’s blog is my contribution to raising awareness, hoping to encourage my friends, family and colleagues to talk to the men in their lives about their health.

Continue reading

Posted on 12/11/2021 | 0 Comments